Select language:  
1800 620 420
Close menu

Identifying high-risk smouldering myeloma to improve patient outcomes

Dr Melissa Cantley hopes that those who have this pre-canerous condition will be able to be tested to understand their risk of developing myeloma.

  • Myeloma
  • Research
Read more
Dr Melissa Cantley in the lab

PBAC update on two myeloma drugs

These two myeloma drugs were not recommended for listing on the PBS.

  • Myeloma
  • Treatments and side-effects
Read more
Elotuzumab

Same cancer, same drug but our access to treatment was anything but consistent

They’re three women all battling an incurable type of blood cancer, but Neda, Nikki and Shirley have felt hardship in very different ways.

  • Myeloma
Read more
Neda Masters

Daratumumab – first new myeloma agent PBAC-recommended in years

The drug has received a positive recommendation for PBS listing.

  • Advocacy and policy
  • Myeloma
  • Treatments and side-effects
Read more
Darzalex

Shirley’s “so well” on her latest treatment – daratumumab

Shirley Irwin has had radiotherapy and two transplants, had surgery, five different lines of treatment, and relapsed twice.

  • Myeloma
  • Treatments and side-effects
Read more
Bruce and Shirley Irwin on the beach

Research aims to improve QOL by decreasing treatment toxicity

Kate Vandyke is leading exciting research examining whether a new inhibitor can be used to prepare myeloma patients for therapies and increase their efficacy.

  • Myeloma
  • Research
Read more
Kate van Dyke

One in 110,000: Neda’s Story

Neda has experienced first-hand the benefit of Leukaemia Foundation support services - all thanks to the generosity of Australians.

  • Myeloma
Read more
Woman in a headscarf smiling at the camera

Davina’s selfless generosity could spark research breakthrough

Through a Gift in her Will, Davina's been able to fund strategic research projects to help people with blood cancer.

  • Myeloma
  • Our supporters
  • Research
Read more
Davina Sickerdick standing outside Buckingham Palace in London

Jeanette takes nothing for granted

  • Myeloma
Read more
Jeanette Kingston and family on the beach

First ‘next generation’ genomic test available in six months

Australian patient outcomes in the rapidly changing fields of genomic testing and precision medicine has been accelerated by Leukaemia Foundation funding. 

  • Myeloma
  • Research
Read more
Anna Brown in the lab